Human neutrophil antibodies in a blood donor population: a lookback study

Background and Objectives  Human neutrophil antibodies (HNA) have been associated with severe transfusion‐related acute lung injury (TRALI). We identified HNA antibodies in a blood donor population and performed an observational lookback on patients who received products from these donors to determine whether TRALI was associated with these transfusions.

[1]  R. Weiskopf,et al.  Transfusion-related acute lung injury: incidence and risk factors. , 2012, Blood.

[2]  O. Gajic,et al.  The Leukocyte Antibody Prevalence Study‐II (LAPS‐II): a retrospective cohort study of transfusion‐related acute lung injury in recipients of high‐plasma‐volume human leukocyte antigen antibody–positive or –negative components , 2011, Transfusion.

[3]  E. Beckers,et al.  Male‐only fresh‐frozen plasma for transfusion‐related acute lung injury prevention: before‐and‐after comparative cohort study , 2011, Transfusion.

[4]  S. Glynn,et al.  The frequency and specificity of human neutrophil antigen antibodies in a blood donor population , 2011, Transfusion.

[5]  S. Adams,et al.  Screening plateletpheresis donors for HLA antibodies on two high‐throughput platforms and correlation with recipient outcome , 2011, Transfusion.

[6]  J. Bux.  Antibody‐mediated (immune) transfusion‐related acute lung injury , 2011, Vox sanguinis.

[7]  N. Soni,et al.  Ten years of hemovigilance reports of transfusion‐related acute lung injury in the United Kingdom and the impact of preferential use of male donor plasma , 2009, Transfusion.

[8]  B. Keller-Stanislawski,et al.  Specificities of leucocyte alloantibodies in transfusion‐related acute lung injury and results of leucocyte antibody screening of blood donors , 2008, Vox sanguinis.

[9]  J. G. van der Bom,et al.  The role of donor antibodies in the pathogenesis of transfusion‐related acute lung injury: a systematic review , 2008, Transfusion.

[10]  S. Adams,et al.  A preliminary comparison of the prevalence of transfusion reactions in recipients of platelet components from donors with and without human leucocyte antigen antibodies , 2008, Vox sanguinis.

[11]  D. Stroncek,et al.  Patient‐specific transfusion‐related acute lung injury , 2007, Vox sanguinis.

[12]  J. Nowak,et al.  Leucocyte antibodies in blood donors and a look back on recipients of their blood components , 2007, Vox sanguinis.

[13]  R. Benjamin,et al.  Transfusion‐related acute lung injury surveillance (2003‐2005) and the potential impact of the selective use of plasma from male donors in the American Red Cross , 2007, Transfusion.

[14]  D. Stroncek,et al.  The transfusion of neutrophil‐specific antibodies causes leukopenia and a broad spectrum of pulmonary reactions , 2007, Transfusion.

[15]  C. Silliman,et al.  Transfusion-related acute lung injury. , 2005, Blood.

[16]  M. Nakagawa,et al.  Recipients of blood from a donor with multiple HLA antibodies: a lookback study of transfusion‐related acute lung injury , 2004, Transfusion.

[17]  C. Chapman,et al.  Transfusion‐related acute lung injury caused by two donors with anti‐human leucocyte antigen class II antibodies: a look‐back investigation , 2004, Transfusion medicine.

[18]  R. Aster,et al.  TRALI due to granulocyte‐agglutinating human neutrophil antigen‐3a (5b) alloantibodies in donor plasma: a report of 2 fatalities , 2003, Transfusion.

[19]  G. Lucas,et al.  Transfusion-related acute lung injury: a 5-year look-back study. , 2002, Transfusion medicine.

[20]  L. Cooling.  Transfusion-related acute lung injury. , 2002, JAMA.

[21]  P. Holland,et al.  Transfusion-Related Acute Lung Injury Report of a Clinical Look-Back Investigation , 2002 .